Launch week offerEnds in00h00m00s

annual Promonthly Pro

Mitchell Creinin

Has grant

Professor, Director of Family Planning

University of California Davis School of Medicine

United States

Research Interests

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Explore related searches

Professors in United States

About

Mitchell Creinin is a Professor and the Director of Family Planning at the University of California Davis School of Medicine in the United States. His research areas include contraceptive safety and efficacy, with recent publications focusing on the use of levonorgestrel intrauterine devices, cardiovascular risks related to hormonal contraceptives, and best practices in the assessment of reproductive health interventions. Professor Creinin's work emphasizes the importance of accurate data analysis in contraceptive studies and the clinical implications of hormone-related side effects.

Recent Grants

Grant: Close

NICHD: R&D: A PHASE 2B STUDY TO EVALUATE THE EFFICACY AND SAFETY OF SUBCUTANEOUS LEVONORGESTREL BUTANOATE FOR FEMALE CONTRACEPTION: SEVERABLE

Open Date: 2025-08-01

Close Date: 2026-02-28

Grant: Close

CCTN-CONTRACEPTIVE DEVELOPMENT PROGRAM – CORE FUNCTION ACTIVITIES FOR SITES OF FEMALE CONTRACEPTIVE STUDIES - UC DAVIS

Open Date: 2024-08-01

Close Date: 2025-07-31

Grant: Close

CCTN-CONTRACEPTIVE DEVELOPMENT PROGRAM-NICHD CONTRACEPTIVE CLINICAL TRIALS NETWORK-FEMALE SITES-CORE FUNCTION ACTIVITIES

Open Date: 2020-08-01

Close Date: 2021-07-31

Grant: Close

CCTN - CLINICAL EVALUATION OF LONG ACTING REVERSIBLE CONTRACEPTIVES

Open Date: 2015-09-25

Close Date: 2018-09-24

Grant: Close

CLINICAL EVALUATION OF NOVEL PRODUCTS FOR FEMALE CONTRACEPTION

Open Date: 2014-09-19

Close Date: 2021-12-31

Articles (33)

Year:

2026

Year:

2026

Year:

2026

Year:

2026

Year:

2026

Year:

2026

Year:

2026

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2021

Collaborators (13)

Jeffrey Jensen

Oregon Health & Science University

UNITED STATES

View details

Bliss Kaneshiro

Chief, Professor

University of Hawaii

UNITED STATES

View details

Prasanth Surampudi

Clinical Professor

University of California, Davis

UNITED STATES

View details

Jonathan Douxfils

Professeur

University of Namur

BELGIUM

View details

John Reynolds-Wright

CSO/NES Clinical Lecturer

University of Edinburgh

UNITED KINGDOM

View details

Laura Kair

Professor

University of California, Davis

UNITED STATES

View details

Marie Didembourg

University of Namur

BELGIUM

View details

Melissa Chen

Associate Professor

UC Davis Health System

UNITED STATES

View details

Brian Nguyen

Associate Professor

University of Southern California

UNITED STATES

View details

John K. Amory

Professor and Associate Dean

University of Washington

UNITED STATES

View details

Médéa Locquet

University of Namur

BELGIUM

View details

Lori Gawron

University of Utah

UNITED STATES

View details

Jill Brown

Professor and Vice Chair

Uniformed Services University of the Health Sciences

UNITED STATES

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Mitchell Creinin

Research Interests

Make your next move.

Explore related searches

About

Recent Grants

Articles (33)

Critical assessment of a prolonged-release eE/DNG contraceptive safety analysis

Conditions That Limit Outpatient Abortion Care at Clinics in the United States

Understanding support needs for people carrying pregnancies with life-limiting fetal conditions: a qualitative study.

Understanding U.S. non-religious hospital inpatient approval mechanisms for induced abortion.

Data interpretation of changes in abortion volume of graduating obstetrics and gynecology residents

Errors in the Society of Family Planning medication management for early pregnancy loss clinical recommendations

Letter to the editor: five-year implant versus other contraception missing correct data

Estetrol/Drospirenone safety in a population with cardiovascular risk factors

Postpartum Care Recommendations from Parents of Premature Infants Requiring Intensive Care

Effects of estetrol/drospirenone on self-reported physical and emotional premenstrual and menstrual symptoms: Data from the phase 3 clinical trial in the United States and Canada.

Etonogestrel implant failure in a woman taking thyroid hormone replacement: A case report.

Contraceptive Efficacy and Comparative Side Effects of a Mini Copper Intrauterine Device

Three-year efficacy, safety, and tolerability outcomes from a phase 3 study of a low-dose copper intrauterine device

Consensus recommendations for measuring the impact of contraception on the menstrual cycle in contraceptive clinical trials

Contraceptive Choices for Premenopausal Women and Breast Cancer Risk

Depomedroxyprogesterone acetate impact on mifepristone action during medication abortion

Levonorgestrel 52 mg intrauterine device placement without uterine sounding: A feasibility study

Professional challenges and abortion after the <i>Dobbs</i> decision

Hormone-related side effects in new users of a levonorgestrel 52-mg intrauterine device

Feasibility study of a single‐handed inserter for levonorgestrel 52 mg intrauterine device placement

Use of at-home sperm concentration testing in a male hormonal contraceptive efficacy clinical trial.

Errors in the use of the FAERS database to assess the safety of Yasmin

Contraceptive counseling training experiences and behaviors among obstetrics and gynecology residents in California and Florida.

Endometrial thickness after dilation and evacuation: A retrospective cohort study

Extending use of levonorgestrel 52 mg intrauterine device to 8 years

Clinical interventions are more accurate than quantitative measurements for defining hemorrhage with dilation and evacuation

Comparing IUC and Tubal Ligation

Levonorgestrel 52 mg intrauterine system efficacy and safety through 8 years of use

Recommendations for standardization of bleeding data analyses in contraceptive studies

Contraceptive plans before preoperative assessment and at procedure in surgical abortion patients

Mifepristone prior to osmotic dilators for dilation and evacuation cervical preparation: A randomized, double-blind, placebo-controlled pilot study

Society of Family Planning Committee statement on IUD nomenclature

Pharmacists’ knowledge, perspectives, and experiences with mifepristone dispensing for medication abortion

Collaborators (13)

Jeffrey Jensen

Bliss Kaneshiro

Prasanth Surampudi

Jonathan Douxfils

John Reynolds-Wright

Laura Kair

Marie Didembourg

Melissa Chen

Brian Nguyen

John K. Amory

Médéa Locquet

Lori Gawron

Jill Brown

Make your next move.